Danaher Free Cash Flow 2010-2024 | DHR
Danaher annual/quarterly free cash flow history and growth rate from 2010 to 2024. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
- Danaher free cash flow for the quarter ending June 30, 2024 was 2,579.00, a year-over-year.
- Danaher free cash flow for the twelve months ending June 30, 2024 was , a year-over-year.
- Danaher annual free cash flow for 2023 was $5.793B, a 21.82% decline from 2022.
- Danaher annual free cash flow for 2022 was $7.41B, a 3.91% increase from 2021.
- Danaher annual free cash flow for 2021 was $7.131B, a 31.59% increase from 2020.
| Danaher Annual Free Cash Flow |
| 2023 |
5,793.00 |
| 2022 |
7,410.00 |
| 2021 |
7,131.00 |
| 2020 |
5,419.00 |
| 2019 |
3,329.00 |
| 2018 |
3,444.00 |
| 2017 |
2,939.60 |
| 2016 |
2,942.00 |
| 2015 |
3,349.30 |
| 2014 |
3,293.00 |
| 2013 |
3,047.20 |
| 2012 |
2,956.70 |
| 2011 |
2,291.80 |
| 2010 |
1,894.90 |
| 2009 |
1,630.41 |
| Danaher Quarterly Free Cash Flow |
| 2024-06-30 |
2,579.00 |
| 2024-03-31 |
1,448.00 |
| 2023-12-31 |
5,793.00 |
| 2023-09-30 |
4,572.00 |
| 2023-06-30 |
3,280.00 |
| 2023-03-31 |
1,681.00 |
| 2022-12-31 |
7,410.00 |
| 2022-09-30 |
5,164.00 |
| 2022-06-30 |
3,431.00 |
| 2022-03-31 |
1,720.00 |
| 2021-12-31 |
7,131.00 |
| 2021-09-30 |
5,164.00 |
| 2021-06-30 |
3,448.00 |
| 2021-03-31 |
1,632.00 |
| 2020-12-31 |
5,419.00 |
| 2020-09-30 |
3,513.00 |
| 2020-06-30 |
1,977.00 |
| 2020-03-31 |
687.00 |
| 2019-12-31 |
3,329.00 |
| 2019-09-30 |
2,396.40 |
| 2019-06-30 |
1,592.10 |
| 2019-03-31 |
563.70 |
| 2018-12-31 |
3,444.00 |
| 2018-09-30 |
2,344.70 |
| 2018-06-30 |
1,574.60 |
| 2018-03-31 |
691.40 |
| 2017-12-31 |
2,939.60 |
| 2017-09-30 |
2,229.60 |
| 2017-06-30 |
1,294.20 |
| 2017-03-31 |
402.30 |
| 2016-12-31 |
2,942.00 |
| 2016-09-30 |
2,457.90 |
| 2016-06-30 |
1,786.30 |
| 2016-03-31 |
650.20 |
| 2015-12-31 |
3,349.30 |
| 2015-09-30 |
2,218.60 |
| 2015-06-30 |
1,364.40 |
| 2015-03-31 |
406.60 |
| 2014-12-31 |
3,293.00 |
| 2014-09-30 |
2,109.70 |
| 2014-06-30 |
1,224.30 |
| 2014-03-31 |
380.30 |
| 2013-12-31 |
3,047.20 |
| 2013-09-30 |
2,115.30 |
| 2013-06-30 |
1,283.20 |
| 2013-03-31 |
520.20 |
| 2012-12-31 |
2,956.70 |
| 2012-09-30 |
2,281.90 |
| 2012-06-30 |
1,425.60 |
| 2012-03-31 |
527.50 |
| 2011-12-31 |
2,291.80 |
| 2011-09-30 |
1,594.54 |
| 2011-06-30 |
997.46 |
| 2011-03-31 |
392.59 |
| 2010-12-31 |
1,894.90 |
| 2010-09-30 |
1,371.60 |
| 2010-06-30 |
843.31 |
| 2010-03-31 |
356.93 |
| 2009-12-31 |
1,630.41 |
| 2009-09-30 |
1,193.47 |
| 2009-06-30 |
720.57 |
| 2009-03-31 |
280.61 |
| Sector |
Industry |
Market Cap |
Revenue |
| Multi-Sector Conglomerates |
Diversified Operations |
$199.641B |
$23.890B |
|
Danaher Corporation is a global conglomerate that designs, manufactures and markets diverse lines of professional, industrial, commercial and consumer products. The company's segmental details are provided below: Life Sciences segment offers a broad range of research tools used to analyze a range of critical areas including genes, proteins, metabolites and cells to understand the causes of diseases, identify new therapies, and test new drugs and vaccines. Range of industries served includes biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial. Diagnostics segment offers analytical instruments, reagents, consumables, software and services that are deployed in reference laboratories, hospitals, physicians' offices and other critical care settings. It helps to diagnose diseases and take suitable treatment decisions. Environmental & Applied Solutions segment offers products and services that help keep food and water supplies safe globally.
|
